文献速递神经康复骨科与运动康复

ULIS-III研究首轮结果:结构化目标设定与结局评估用于上肢痉挛管理

Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
PubMed 文献 · J Rehabil Med · 2021-01-01

ULIS-III是一项国际观察性纵向研究,纳入1004例接受A型肉毒毒素注射联合物理治疗的上肢痉挛成人患者,首轮953例(95%)完成。结构化目标达成量表平均T分为49.8(95%CI 49.2-50.3),67.1%患者达成主要目标;痉挛、疼痛、不自主运动及主动/被动功能均显著改善。上肢痉挛指数和上肢痉挛治疗记录表可作为结构化评估工具。

要点

  • 结构化目标设定与结局评估工具(ULIS指数与治疗记录表)可行且有效。
  • 67.1%患者达成主要目标,不自主运动与关节活动度目标达成率最高。
  • 痉挛、疼痛、不自主运动及功能在治疗周期内均显著改善。

核心结论

  • 上肢痉挛指数和上肢痉挛治疗记录表可作为结构化方法,有效捕获目标设定、治疗输入和结局评估。

研究设计与样本

  • ULIS-III为国际观察性纵向研究(NCT02454803),纳入1004例接受A型肉毒毒素治疗的上肢痉挛成人患者,首轮953例(95%)完成。

主要发现

  • 平均目标达成量表T分为49.8(95%CI 49.2-50.3),67.1%患者达成主要目标。
  • 不自主运动相关目标达成率75.6%,关节活动度相关目标达成率74.4%。
  • 痉挛、疼痛、不自主运动、主动和被动功能等标准化测量在治疗周期内均显著改善。
  • 59.7%患者在A型肉毒毒素注射后接受了治疗师干预。
  • 控制伴随治疗后有显著注射间隔差异(p < 0.001)见于不同商用A型肉毒毒素制剂之间。

临床怎么用

  • 可采用上肢痉挛指数和上肢痉挛治疗记录表结构化记录目标设定、治疗输入与结局,以评估A型肉毒毒素联合物理治疗的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the utility of a structured approach to assessing effectiveness following injection with botulinum toxin-A alongside physical therapies, within the first cycle of the Upper Limb International Spasticity-III (ULIS-III) study. METHODS: ULIS-III (registered at clinicaltrials.gov as NCT02454803) is a large international, observation-al, longitudinal study of adults treated for upper-limb spasticity. It introduces novel methods for the structured evaluation of person-centred goal attainment alongside targeted standardized outcome measures: the Upper limb Spasticity Index, and the Upper Limb Spasticity Therapy Recording Schedule. RESULTS: A total of 953/1,004 enrolled patients (95%) completed cycle 1. Mean overall goal attainment scaling (GAS) T scores were 49.8 (95% confidence interval 49.2-50.3; 67.1% of patients met their primary goal, with highest achievement rates for goals related to involuntary movement, (75.6%) and range of movement (74.4%). Standardized measures of spasticity, pain, involuntary movements, active and passive function, all improved significantly over the treatment cycle. Overall, 59.7% of patients saw a therapist following botulinum toxin-A injection. Interventions varied, as expected, with the set treatment goals. After controlling for concomitant therapies using the upper limb spasticity therapy recording schedule, significant differences in injection intervals (p < 0.001) were seen between the commercially-available botulinum toxin-A agents. CONCLUSION: The results of this study confirm the utility of the Upper Limb Spasticity Index and Upper Limb Spasticity Therapy Recording Schedule as a structured approach to capturing goal-setting, therapy inputs and outcomes assessment.

来源:J Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Turner-Stokes L, Jacinto J, Fheodoroff K, et al. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study. J Rehabil Med. 2021. PMID: 33206198. doi:10.2340/16501977-2770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。